Black Bird Biotech(BBBT)
$0.000.00 (0.00%)
BBBT
Black Bird Biotech financials statements
$0.00
At close:0.00 (0.00%)
Black Bird Biotech (BBBT) Ratios
30 Followers
Black Bird Biotech Ratios
BBBT's free cash flow for Q3 2023 was $-4.90K. For the 2023 fiscal year, BBBT's free cash flow was increased by $0.00 and operating cash flow was $-4.90K. See a summary of the company’s cash flow.
| Ratios | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.16 | 6.52 | 1.08 | 0.00 | 0.00 |
| Quick Ratio | 0.05 | 5.81 | 0.67 | 0.00 | 0.00 |
| Cash Ratio | 0.05 | 4.81 | 0.54 | 0.00 | 0.00 |
| Solvency Ratio | -1.81 | -16.36 | -7.02 | -0.14 | -0.12 |
| Operating Cash Flow Ratio | -1.19 | -9.54 | -6.29 | -0.08 | -0.07 |
| Short-Term Operating Cash Flow Coverage | -1.54 | -17.01 | -13.58 | -0.10 | -0.10 |
| Net Current Asset Value | $ -733.59K | $ 574.16K | $ 7.61K | $ -1.14M | $ -1.02M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 3.07 | 0.08 | 0.36 | 898.84 | 167.34 |
| Debt-to-Equity Ratio | -1.03 | 0.09 | 1.65 | -0.77 | -0.78 |
| Debt-to-Capital Ratio | 34.16 | 0.08 | 0.62 | -3.29 | -3.49 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.34 | 1.16 | 4.57 | -0.00 | -0.00 |
| Debt Service Coverage Ratio | -1.15 | -4.12 | -13.29 | -0.21 | -0.10 |
| Interest Coverage Ratio | -3.48 | -5.09 | -116.60 | -1.93 | -2.22 |
| Debt to Market Cap | 2.70 | 0.01 | 0.01 | 0.05 | 0.66 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Net Debt to EBITDA | -0.52 | 0.31 | 0.01 | -5.97 | -9.42 |
| Profitability Margins | |||||
| Gross Profit Margin | -67.71% | 18.75% | 50.97% | -0.17% | 0.00% |
| EBIT Margin | -1560.24% | -1460.85% | -1187.91% | -840.54% | 0.00% |
| EBITDA Margin | -1452.55% | -1355.88% | -1187.91% | -823.70% | 0.00% |
| Operating Profit Margin | -1560.42% | -1389.20% | -1188.81% | -451.89% | 0.00% |
| Pretax Profit Margin | -2009.09% | -1734.00% | -1198.11% | -686.33% | 0.00% |
| Net Profit Margin | -2009.09% | -1734.00% | -1200.56% | -920.76% | 0.00% |
| Continuous Operations Profit Margin | -2009.09% | -1734.00% | -1198.11% | -840.54% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.20% | 134.16% | 100.00% |
| EBT Per EBIT | 128.75% | 124.82% | 100.78% | 151.88% | 144.98% |
| Return on Assets (ROA) | -759.13% | -233.96% | -548.21% | -16816.86% | -2558.84% |
| Return on Equity (ROE) | 255.13% | -270.26% | -2504.87% | 14.34% | 11.89% |
| Return on Capital Employed (ROCE) | 198.15% | -216.52% | -2480.36% | 7.04% | 8.20% |
| Return on Invested Capital (ROIC) | -6571.45% | -199.18% | -935.19% | 30.17% | 36.83% |
| Return on Tangible Assets | -1237.29% | -262.60% | -548.21% | -16816.86% | -2558.84% |
| Earnings Yield | -668.73% | -41.41% | -12.05% | -0.97% | -10.06% |
| Efficiency Ratios | |||||
| Receivables Turnover | 36.55 | 38.11 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 1.33 | 2.36 | 0.61 | 0.07 | 0.00 |
| Inventory Turnover | 1.57 | 1.14 | 0.71 | 0.00 | 0.00 |
| Fixed Asset Turnover | 11.58 | 9.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.38 | 0.13 | 0.46 | 18.26 | 0.00 |
| Working Capital Turnover Ratio | -1.04 | 0.36 | -0.10 | -0.02 | 0.00 |
| Cash Conversion Cycle | -30.79 | 175.11 | -84.99 | -5478.38 | 0.00 |
| Days of Sales Outstanding | 9.99 | 9.58 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 232.97 | 320.24 | 512.72 | 0.00 | 0.00 |
| Days of Payables Outstanding | 273.74 | 154.71 | 597.71 | 5478.38 | 0.00 |
| Operating Cycle | 242.96 | 329.82 | 512.72 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -258143.50 | -174.05 | -123893.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -258143.50 | -174.05 | -123893.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -1.54 | -17.01 | -13.58 | -0.10 | -0.10 |
| Operating Cash Flow to Sales Ratio | -12.51 | -9.50 | -10.75 | -4.86 | 0.00 |
| Free Cash Flow Yield | -416.28% | -22.82% | -10.79% | -0.51% | -6.32% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.15 | -2.42 | -8.30 | -102.98 | -9.94 |
| Price-to-Sales (P/S) Ratio | 3.00 | 41.88 | 99.67 | 948.19 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.38 | 6.53 | 207.94 | -14.77 | -1.18 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.24 | -4.38 | -9.27 | -195.20 | -15.82 |
| Price-to-Operating Cash Flow Ratio | -0.24 | -4.41 | -9.27 | -195.20 | -15.82 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.04 | -0.03 | 0.00 | -1.29 |
| Enterprise Value Multiple | -0.73 | -2.78 | -8.38 | -121.08 | -23.83 |
| Enterprise Value | 873.37K | 3.93M | 5.73M | 17.72M | 1.99M |
| EV to EBITDA | -0.73 | -2.78 | -8.38 | -121.08 | -23.83 |
| EV to Sales | 10.58 | 37.65 | 99.54 | 997.35 | 0.00 |
| EV to Free Cash Flow | -0.85 | -3.94 | -9.26 | -205.32 | -26.16 |
| EV to Operating Cash Flow | -0.85 | -3.96 | -9.26 | -205.32 | -26.16 |
| Tangible Book Value Per Share | -0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Shareholders’ Equity Per Share | -0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.34 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.34 | 1.00 |
| Interest Burden | 1.29 | 1.19 | 1.01 | 0.82 | 1.45 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 11.59 | 12.98 | 11.77 | 4.52 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 5.49 | 0.40 | 2.53 | 0.00 |
| Income Quality | 0.62 | 0.55 | 0.90 | 0.71 | 0.63 |
Currency in USD
